Shipping disruption and glove supply: the Red Sea, the Panama Canal and Hormuz
Three disruptions in under three years, each hitting glove supply by a different mechanism – freight cost, then raw material cost and manufacturer solvency.
This article was first published in January 2024, during the Red Sea rerouting. It is kept and extended because what looked then like a single disruption turned out to be the first of three in under three years, each hitting glove supply through a different mechanism. Read together they are a reasonable guide to how this category actually behaves under stress.
2023–2024: the Red Sea and the freight mechanism
Attacks on vessels transiting the Red Sea disrupted Suez Canal traffic and prompted major carriers – Maersk, ONE, OOCL, Wallenius Wilhelmsen and Yang Ming among them – to suspend Red Sea operations or reroute around the Cape of Good Hope, adding roughly one to two weeks to Asia–Europe voyage times.
As of late 2023, Goldman Sachs estimated that around 30 % of global container trade was affected, with 70–80 % of vessels rerouted. Two factors compounded it: the seasonal export surge before Chinese New Year, and simultaneous draught restrictions on the Panama Canal reducing daily transits.
The mechanism was freight cost and transit time, not product availability. Gloves continued to be manufactured; they took longer to arrive and cost more to move. For a buyer, the exposure was schedule risk on call-offs and freight-linked price movement.
2026: Hormuz and the raw material mechanism
The 2026 conflict in the Middle East worked differently, and more severely.
Nitrile gloves are made from acrylonitrile butadiene rubber, whose feedstock is petrochemical. The blockade of the Strait of Hormuz created what was described as the largest oil supply shock in decades. Butadiene costs rose sharply – roughly 70 % on some reporting – and the Malaysian Rubber Glove Manufacturers Association warned that shortage of the key raw material was placing immense financial strain on manufacturers and threatening global medical glove supply. Raw material costs across the sector rose by more than 50 %, and Top Glove, the largest manufacturer in the world, raised prices and encouraged customers to switch to natural rubber alternatives.
This time the mechanism was input cost and manufacturer solvency. In April 2026, WRP Asia Pacific – a long-established Malaysian manufacturer – announced the wind-down of its operations and ceased production, with a liquidator appointed. A supplier's factory closing is a different class of problem from a container arriving late.
What the two episodes teach a buyer
Nitrile pricing is energy pricing. There is no version of nitrile glove procurement that is insulated from petrochemical markets. Natural rubber latex, being agricultural, is exposed to different risks – and behaves as a genuine hedge, which is part of why we maintain both materials in the range.
Single-source supply is the concentrated risk, not single-country supply. Malaysia's share of world glove manufacturing means most buyers are exposed to the same geography regardless. What distinguishes a resilient supply position is having qualified more than one manufacturer for the same specification, with documentation already in place, so a substitution does not require a new approval cycle.
Long framework agreements need a raw material clause. A four-year fixed price on a petrochemical-derived product is a bet on energy markets by whichever party carries it. Public buyers who insist on fixed pricing across a long term should expect a risk premium in the bid, or a supplier who cannot honour it.
Lead times are the first thing to move, and the last to recover. Freight normalises faster than manufacturing capacity. Where a programme has a fixed clinical or field date, the buffer belongs in the schedule rather than in the assumption.
What we do about it
Our position on this is a sourcing practice rather than a promise:
Frequently asked questions
Should we switch to latex to avoid petrochemical exposure? Not as a blanket policy. Latex is priced on an agricultural cycle and does behave as a hedge, but it reintroduces Type I allergy risk, which for most clinical settings is the more serious consideration. It is a reasonable option for non-clinical and food-handling volume. See where latex still outperforms.
How much stock should we hold during a disruption? Enough to cover the extended lead time plus the call-off cycle, not more. Gloves have a declared five-year shelf life that is conditional on storage, and stock held in an uncontrolled space during a hot summer can lose its compliance basis. Buffer in weeks, and store properly.
Does a fixed-price framework protect us? It transfers the risk to the supplier, which protects you only for as long as the supplier remains solvent. WRP's closure in April 2026 is the relevant precedent. Assess the supplier's financial strength as seriously as the price.
Is air freight a solution? For emergency volumes, yes, and we have delivered that way. For routine supply the cost per box makes it unsustainable, and the correct answer is schedule buffer rather than mode change.
Key takeaways
Seventeen years sourcing and supplying medical gloves and PPE to governments, UN agencies, NGOs and healthcare systems. Writes on glove standards, quality management and responsible sourcing for institutional buyers, working from the source standards rather than secondary summaries.
View profile on LinkedIn
